Propanc Biopharma Management
Management criteria checks 4/4
Propanc Biopharma's El consejero delegado es James Nathanielsz , nombrado en Oct 2007, tiene un mandato de 16.17 años. la remuneración anual total es $430.28K , compuesta por 92.9% salario y 7.1% primas, incluidas acciones y opciones de la empresa. posee directamente 0.039% de las acciones de la empresa, por valor de $77.19 . La antigüedad media del equipo directivo y del consejo de administración es de 13 años y 7.9 años respectivamente.
Key information
James Nathanielsz
Chief executive officer
US$430.3k
Total compensation
| CEO salary percentage | 92.9% |
| CEO tenure | 16.5yrs |
| CEO ownership | 0.01% |
| Management average tenure | 13.3yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$3m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | US$430k | US$400k | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | n/a | n/a | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$4m |
| Jun 30 2022 | US$452k | US$320k | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | n/a | n/a | -US$3m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | US$541k | US$299k | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$43k |
| Dec 31 2020 | n/a | n/a | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | US$590k | US$358k | -US$5m |
| Mar 31 2020 | n/a | n/a | -US$8m |
| Dec 31 2019 | n/a | n/a | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | US$989k | US$422k | -US$6m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | n/a | n/a | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$7m |
| Jun 30 2018 | US$576k | US$285k | -US$7m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | n/a | n/a | -US$7m |
| Sep 30 2017 | n/a | n/a | -US$9m |
| Jun 30 2017 | US$307k | US$244k | -US$8m |
Compensación vs. Mercado: James($USD430.28K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD740.57K).
Compensación vs. Ingresos: La compensación de James ha sido consistente con los resultados de la empresa en el último año.
CEO
James Nathanielsz (49 yo)
16.5yrs
Tenure
US$430,284
Compensation
Mr. James Nathanielsz serves as the Executive Chairman, Secretary and Treasurer of Propanc Biopharma, Inc., and has been its Director since October 15, 2007. He has been Chief Executive Officer at Propanc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 16.5yrs | US$430.28k | 0.012% $ 14.0 | |
| Chief Scientific Officer | 4.9yrs | US$35.99k | 0.0047% $ 5.5 | |
| Chief Medical Officer & Member of Scientific Advisory Board | 13.3yrs | US$18.23k | no data |
13.3yrs
Average Tenure
Equipo directivo experimentado: PPCBEl equipo directivo de la empresa es veterano y experimentado (13 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 16.5yrs | US$430.28k | 0.012% $ 14.0 | |
| Chief Scientific Officer | 16.2yrs | US$35.99k | 0.0047% $ 5.5 | |
| Chief Medical Officer & Member of Scientific Advisory Board | no data | US$18.23k | no data | |
| Member of Scientific Advisory Board | 4.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.3yrs | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | US$84.00k | 0.0039% $ 4.5 |
8.3yrs
Average Tenure
66yo
Average Age
Junta con experiencia: La junta directiva de PPCB se considera experimentada (7.9 años de antigüedad promedio).